EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
CRA International, Inc.
CRAI

CRAI CRA International, Inc.

CRA International, Inc. · NASDAQ
Market Closed
161.88
▼ ⁦-0.97%⁩ (-1.58)
Market Cap$1.0B
Beta0.65
52w Low52w High
132.17227.29
Last Week
⁦-6.21%⁩
Last Month
⁦-3.93%⁩
Last 3 Months
⁦+14.36%⁩
Last Year
⁦-16.35%⁩
EL7 Factor Analysis
How we score this
Overall41
Weak — below market medianContrarianF 4/9SafeBetter than 41% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
54
21.3x▼17.8xAround median
▸
Growth
33
11.5%▲7.1%Bottom tier
▸
Quality
69
12.8%▲4.5%Top tier
▸
Safety
58
2.8x▼2.6xAround median
▸
Capital Return
48
1.26%▼2.12%Around median
▸
Momentum
34
-12.9%▼2.9%Bottom tier
▸
Sentiment
23
33Bottom tier
Fair Value
Low confidenceCurrent price$162
Analyst target · 2 analysts
$194
⁦+20%⁩
See it undervalued
Range ⁦$194–$194⁩
vs
DCF (estimate)
$27
⁦-83%⁩
Sees it clearly overvalued
⁦7.9⁩% discount · ⁦1⁩% growth
Bottom lineThe two methods disagree — estimate range ⁦$27–$194⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 2 analysts setting price target
$194.00
⁦+19.8%⁩
Current Price $161.88·Median $194.00
Low
$194.00
High
$194.00
Street summary

Price Forecast Analysis for CRA International Stock

CRAI stock shows a state of complete stability in analyst estimates during recent periods (1, 7, and 30 days), with the target price stabilizing at 194 dollars. This consistency reflects a full consensus among the following analysts (only 2 analysts), with zero Dispersion between the high and low target price, indicating a unified view regarding the fair value of the stock at the current time.

As of 2026-05-22
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 4.00
Buy
Analyst coverage
2
Buy conviction
50%
Mixed
Target dispersion
0%
Analyst ratings over time2 analysts rating
1
1
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months4.00 → 4.00
Recent analyst moves
  • = Reiterate2024-08-06
    Barrington
    —· $194.00
  • = Reiterate2022-08-08
    Barrington
    —· $120.00
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    21.30x
    5.69x45.54x
    Cheap
  • Forward P/E
    17.39x
    4.57x36.58x
    Near median
  • EV / EBITDA
    13.75x
    3.43x27.47x
    Near median
  • FCF Yield
    2.0%
    -32.7%11.5%
    Strong
  • Revenue Growth YoY
    11.5%
    -10.7%43.4%
    Near median
  • EPS Growth YoY
    -8.2%
    -128.3%132.7%
    Near median
  • Gross Margin
    45.5%
    8.6%54.6%
    Strong
  • ROIC
    12.8%
    -25.3%19.6%
    Strong
  • Net Debt / EBITDA
    2.78x
    0.55x4.37x
    Near median
  • Dividend Yield
    1.3%
    0.1%4.8%
    Low
  • Payout Ratio
    26.8%
    6.6%80.8%
    Moderate
  • Altman Z-Score
    3.08
    -5.667.97
    Above average
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-08-06 data

Company Overview

CRA International, also known as Charles River Associates, operates as a specialized consulting firm providing litigation and regulatory services and management consulting. Its portfolio includes antitrust and competition economics, finance, forensic services and investigations, intellectual property, life sciences, energy, and risk analytics; revenue is generated from economic expert engagements, disputes, investigations, and strategic consulting assignments performed by teams of consultants for clients.

In fiscal Q2 2026, CRA International reported record quarterly revenue of $210.8 million, up 12.8% year over year, versus EDGAR-reported net income of $13.5 million, equivalent to a calculated net income margin of approximately 6.4%. Revenue increased from $201.0 million and net income from $11.1 million in fiscal Q1 2026. In fiscal 2025, revenue was $751.6 million, net income was $54.8 million, and earnings per share were $8.14.

Growth was broad-based in fiscal Q2 2026; eight practices representing 95% of total revenue grew, six practices achieved double-digit growth, and the antitrust and competition economics practice posted its highest quarterly revenue. Revenue from litigation and regulatory services increased 10.1%, North American operations grew 8.7%, and international operations grew 32.9%. For the first half of fiscal 2026, revenue on a constant-currency basis was $408.8 million, and adjusted earnings before interest, taxes, depreciation, and amortization were $49.7 million, with a margin of 12.2%.

What's Driving the Stock

  • Management raised its fiscal 2026 revenue guidance on a constant-currency basis to a range of $805 million to $820 million, compared with the previous range of $785 million to $805 million, while maintaining its adjusted earnings before interest, taxes, depreciation, and amortization margin guidance at 12% to 13%.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

The antitrust and competition economics practice recorded its sixth consecutive record quarter in fiscal Q2 2026, benefiting from global merger activity of $2.85 trillion in the first half of 2026. Its engagements included providing economic advice to Fivetran regarding its merger with dbt Labs, which was completed on June 1, 2026.
  • The energy and life sciences practices grew by more than 20% year over year in fiscal Q2 2026. The energy practice secured a multiyear engagement from PJM to develop enhanced data center load forecasts, while the life sciences practice supported a global launch strategy for a potential oncology product for a multinational pharmaceutical company.
  • Growth in the forensic services and investigations practice exceeded 20% year over year, and the practice posted its highest quarterly revenue, driven by cyber incident response and crisis management work; one example was its response to a Canvas software outage that affected more than 8,000 universities. Management also described artificial intelligence as enhancing CRA's productivity while simultaneously increasing the complexity of hacker attacks and demand for response services.
  • The consultant headcount increased 3.3% year over year to 968 at the end of fiscal Q2 2026, and the utilization rate reached 77%, compared with 76% a year earlier. The average weekly inflow of project leads and the number of new projects also achieved double-digit growth, while the contribution from approximately 30 vice presidents who joined during 2025 exceeded management's expectations during the first half of fiscal 2026.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +CRA combines record revenue growth with improved operating efficiency; revenue increased 12.8% year over year in fiscal Q2 2026, while adjusted selling, general, and administrative expenses, excluding commissions paid to nonemployee experts, declined to 15.5% of revenue from 16.3% a year earlier.
    • +The diversity of growth reduces reliance on a single practice in fiscal Q2 2026 results; eight practices representing 95% of revenue contributed to growth, six of them posted double-digit growth, and international operations grew 32.9%.
    • +The outlook is supported by the increase in fiscal 2026 revenue guidance to $805–$820 million, alongside double-digit growth in the inflow of project opportunities and new project originations. Management also said that new energy and life sciences opportunities are converting into engagements at historically high rates.
    • +The company returned $31.4 million to shareholders in fiscal Q2 2026, including $27.8 million to repurchase approximately 193 thousand shares and $3.6 million in dividends. Total repurchases since the beginning of fiscal 2026 amounted to approximately $49.3 million for 309 thousand shares, with $16.6 million remaining under the repurchase authorization.

    ▼ Selling Case6 pts

    • −Net debt increased to $197.6 million at the end of fiscal Q2 2026, resulting from cash of $21.4 million and borrowings of $219 million, while total liquidity was only $98.7 million. The company explained that the borrowings funded working capital needs and the bonus cycle, but the debt level increases cash flow sensitivity to interest expense and collections.
    • −The collection cycle deteriorated, as days sales outstanding increased to 113 days at the end of fiscal Q2 2026 from 100 days at the end of fiscal Q1 2026, comprising 68 days of billed receivables and 45 days of unbilled revenue. A continuation of this trend could increase the need for borrowing to finance working capital.
    • −Management expects higher forgivable loan amortization, a noncash expense included in earnings before interest, taxes, depreciation, and amortization metrics, of approximately $15 million in fiscal 2026 because of investment in talent. The increase exceeded $9 million in the first half of fiscal 2026, with an increase of slightly more than $5 million expected in the second half compared with the corresponding period of fiscal 2025.
    • −The adjusted effective tax rate increased to 32.6% in fiscal Q2 2026 from 29.0% a year earlier, primarily because of higher nondeductible executive compensation. Management expects a tax rate of between 33% and 34% for the remainder of fiscal 2026, which could limit the conversion of operating profit growth into net income.
    • −The fiscal 2026 outlook comes from record levels that make comparisons difficult; the chief executive officer acknowledged that the company is forecasting from financial levels it has never achieved before. Fiscal 2025 also included an additional week with a high concentration of holidays, and management estimated its impact on the annual growth rate at approximately 100 to 150 basis points, complicating comparisons in fiscal Q4 2026.
    • −Net insider activity during the three months ended with the latest transaction on August 25, 2026, was $1.5 million in sales, with nine sales and no purchases recorded. This is a weak trading signal relative to operational and financial risks because insider sales may be prearranged unless the data states otherwise.

    Valuation

    The consensus analyst target is $194, with the highest and lowest targets both at the same level and a consensus rating of "Buy," but the absence of dispersion among the targets does not provide a broad range of differing estimates. The target is approximately 14.6% below the 52-week range high of $227.29 and approximately 46.8% above its low of $132.17; therefore, the record revenue track record and raised guidance should be weighed against higher net debt, slower collections, and increases in the tax rate and noncash amortization.

    BuyAnalyst target: $194(+19.8%)

    Figures in the text are as of 2026-09-02; the live price is shown at the top of the page.

    FAQ

    What is driving CRAI's growth in fiscal 2026?

    Fiscal Q2 2026 revenue reached a record $210.8 million, up 12.8% year over year. Eight practices representing 95% of revenue contributed to growth, and six practices achieved double-digit growth. International operations also increased 32.9%, while the inflow of new project opportunities and project originations grew at double-digit rates.

    What is CRA International's guidance for fiscal 2026?

    Management raised the expected revenue range on a constant-currency basis to $805–$820 million from a previous range of $785–$805 million. It maintained its adjusted earnings before interest, taxes, depreciation, and amortization margin guidance at 12% to 13%. Management also expects the constant-currency adjustment to reduce reported annual revenue by approximately $2.5 million and earnings before interest, taxes, depreciation, and amortization by less than $250 thousand.

    How does CRAI benefit from demand related to artificial intelligence and data centers?

    PJM selected CRA's energy practice in fiscal Q2 2026 for a multiyear engagement to develop data center load forecasts. The practice also advises data center developers and operators on site selection, energy procurement, and development strategies in the United States. In forensic services and investigations, management believes that artificial intelligence tools increase CRA's efficiency, but also enhance hackers' capabilities and the complexity of cybersecurity incidents, supporting demand for incident response.

    Does CRAI's growth depend on merger and acquisition activity?

    The antitrust and competition economics practice benefited from global merger activity of $2.85 trillion in the first half of 2026 and recorded its sixth consecutive record quarter. CRA provided economic advice to Fivetran regarding the competitive and regulatory aspects of its merger with dbt Labs in the United States, and the transaction was completed on June 1, 2026. However, fiscal Q2 2026 growth was also distributed across energy, life sciences, forensic services and investigations, intellectual property, finance, and risk analytics.

    What are CRAI's main balance sheet and cash flow risks?

    The company ended fiscal Q2 2026 with net debt of $197.6 million, resulting from $219 million in borrowings and $21.4 million in cash. Total liquidity was $98.7 million, including $77.3 million of available capacity under the credit facility. Days sales outstanding also increased to 113 days from 100 days in the previous quarter, alongside cash spending of $18.2 million on talent investments.

    How does CRA International return capital to shareholders?

    The company returned $31.4 million to shareholders during fiscal Q2 2026. This included $27.8 million to repurchase approximately 193 thousand shares at an average of $144 per share, in addition to dividends of $3.6 million. Since the beginning of fiscal 2026, it has spent $49.3 million to repurchase 309 thousand shares at an average of $160, with $16.6 million remaining available under the program.